Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Zomedica Q4 2023 GAAP EPS $(0.02), Sales $7.337M Beat $7.000M Estimate

Author: Benzinga Newsdesk | April 01, 2024 04:28pm
Zomedica (AMEX:ZOM) reported quarterly losses of $(0.02) per share. The company reported quarterly sales of $7.337 million which beat the analyst consensus estimate of $7.000 million by 4.81 percent. This is a 19.17 percent increase over sales of $6.157 million the same period last year.

Posted In: ZOM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist